Host cytokine responses induced after overnight stimulation with novel M. tuberculosis infection phase-dependent antigens show promise as diagnostic candidates for TB disease.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      Background: We previously identified Mycobacterium tuberculosis (M.tb) antigen-induced host markers that showed promise as TB diagnostic candidates in 7-day whole blood culture supernatants. The aim of the present study was to evaluate the utility of these markers further, and cross-compare results with short-term antigen stimulated and unstimulated culture supernatants.
      Methods: We recruited 15 culture confirmed TB cases and 15 non-TB cases from a high-TB endemic community in Cape Town, South Africa into a pilot case-control study from an on-going larger study. Blood samples collected from study participants were stimulated with 4 M.tb antigens that were previously identified as promising (ESAT6/CFP10 (early secreted), Rv2029c (latency), Rv2032 (latency) and Rv2389c (rpf)) in a 7-day or overnight culture assay. Supernatants were also collected form the standard QuantiFERON In Tube (QFT-IT) test. The levels of 26 host markers were evaluated in the three culture supernatants using the Luminex platform.
      Results: The unstimulated levels of CRP, Serum amyloid P (SAP) and serum amyloid A (SAA) and ESAT-6/CFP-10 specific IP-10 and SAA were amongst the best discriminatory markers in all 3 assays, ascertaining TB with AUC of 72-84%. Four-marker models accurately classified up to 92%, 100% and 100% of study participants in the overnight, 7-day and Quantiferon culture supernatants, respectively, after leave-one-out cross validation.
      Conclusion: Unstimulated and antigen-specific levels of CRP, SAA, IP-10, MMP-2 and sCD40L hold promise as diagnostic candidates for TB disease in short-term stimulation assays. Larger studies are required to validate these findings but the data suggest that antigen-specific cytokine production and in particular mutimarker biosignatures might contribute to future diagnostic strategies.
    • References:
      Clin Vaccine Immunol. 2011 Apr;18(4):676-83. (PMID: 21248154)
      Clin Vaccine Immunol. 2009 Aug;16(8):1203-12. (PMID: 19553548)
      BMC Infect Dis. 2012 Jan 20;12:10. (PMID: 22260319)
      Expert Rev Anti Infect Ther. 2011 Apr;9(4):457-69. (PMID: 21504402)
      Int J Tuberc Lung Dis. 2010 Sep;14(9):1127-31. (PMID: 20819257)
      J Surg Oncol. 2011 Jan 1;103(1):62-8. (PMID: 21031427)
      Eur Respir J. 2011 Jan;37(1):100-11. (PMID: 20847080)
      Protein Expr Purif. 2000 Feb;18(1):95-9. (PMID: 10648174)
      J Appl Microbiol. 2008 Oct;105(4):1121-7. (PMID: 18843791)
      Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009593. (PMID: 23440842)
      Anticancer Res. 2009 Jul;29(7):2513-7. (PMID: 19596921)
      Annu Rev Microbiol. 2001;55:139-63. (PMID: 11544352)
      Clin Chem Lab Med. 2010 Apr;48(4):493-9. (PMID: 20184536)
      PLoS One. 2013 May 15;8(5):e64226. (PMID: 23691173)
      Int J Tuberc Lung Dis. 2011 Dec;15(12):1567-72. (PMID: 22005110)
      Mediators Inflamm. 2013;2013:981984. (PMID: 24327799)
      Oncol Rep. 2013 Feb;29(2):469-73. (PMID: 23135313)
      PLoS One. 2012;7(6):e38501. (PMID: 22693640)
      Infection. 1989 Jan-Feb;17(1):13-4. (PMID: 2537799)
      PLoS One. 2008;3(12):e4057. (PMID: 19129940)
      Clin Exp Immunol. 2008 Jul;153(1):56-62. (PMID: 18460016)
      J Clin Microbiol. 2008 Jan;46(1):171-6. (PMID: 17942645)
      Trends Microbiol. 2009 May;17(5):183-8. (PMID: 19375916)
      Biom J. 2005 Aug;47(4):458-72. (PMID: 16161804)
      Hepatogastroenterology. 2011 Nov-Dec;58(112):2015-9. (PMID: 22024074)
      Cell Host Microbe. 2008 Sep 11;4(3):219-28. (PMID: 18779048)
      Trans R Soc Trop Med Hyg. 2005 Dec;99(12):893-900. (PMID: 16139316)
      PLoS One. 2011;6(12):e28754. (PMID: 22216109)
      Ann N Y Acad Sci. 2007 Mar;1098:437-45. (PMID: 17435148)
      Biol Chem. 2008 May;389(5):497-511. (PMID: 18953716)
      Am J Trop Med Hyg. 2012 Aug;87(2):197-201. (PMID: 22855746)
      BMC Pulm Med. 2009 May 16;9:21. (PMID: 19445695)
      Am J Respir Crit Care Med. 2007 Mar 15;175(6):529-31. (PMID: 17341646)
      Tuberculosis (Edinb). 2012 Mar;92(2):148-59. (PMID: 22226907)
    • Accession Number:
      0 (Antigens, Bacterial)
      0 (Biomarkers)
      0 (Cytokines)
    • Publication Date:
      Date Created: 20140716 Date Completed: 20151014 Latest Revision: 20211021
    • Publication Date:
      20240104
    • Accession Number:
      PMC4099213
    • Accession Number:
      10.1371/journal.pone.0102584
    • Accession Number:
      25025278